These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 22503803

  • 1. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O.
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 3. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG, Bockenhauer D.
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [Abstract] [Full Text] [Related]

  • 4. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [Abstract] [Full Text] [Related]

  • 5. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S, Carmosino M, Gerbino A, Svelto M, Procino G.
    Int J Mol Sci; 2017 Nov 10; 18(11):. PubMed ID: 29125546
    [Abstract] [Full Text] [Related]

  • 6. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG.
    Prog Mol Biol Transl Sci; 2009 Nov 10; 89():15-29. PubMed ID: 20374732
    [Abstract] [Full Text] [Related]

  • 7. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C, Higgins PJ, Zhang W.
    Cells; 2020 Sep 26; 9(10):. PubMed ID: 32993088
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
    Moeller HB, Rittig S, Fenton RA.
    Endocr Rev; 2013 Apr 26; 34(2):278-301. PubMed ID: 23360744
    [Abstract] [Full Text] [Related]

  • 9. [Nephrogenic diabetes insipidus].
    Evrard A, Lefebvre J, Vantyghem M.
    Ann Endocrinol (Paris); 1999 Dec 26; 60(6):457-64. PubMed ID: 10617799
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic diabetes insipidus.
    Bichet DG.
    Am J Med; 1998 Nov 26; 105(5):431-42. PubMed ID: 9831428
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic Diabetes Insipidus.
    Kavanagh C, Uy NS.
    Pediatr Clin North Am; 2019 Feb 26; 66(1):227-234. PubMed ID: 30454745
    [Abstract] [Full Text] [Related]

  • 12. [Nephrogenic diabetes insipidus].
    Ishikawa S.
    Nihon Rinsho; 1996 Mar 26; 54(3):819-24. PubMed ID: 8904243
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
    Makretskaya NA, Nanzanova US, Hamaganova IR, Eremina ER, Tiulpakov AN.
    Probl Endokrinol (Mosk); 2023 May 12; 69(2):75-79. PubMed ID: 37448274
    [Abstract] [Full Text] [Related]

  • 14. Genetic basis of nephrogenic diabetes insipidus.
    Hureaux M, Vargas-Poussou R.
    Mol Cell Endocrinol; 2023 Jan 15; 560():111825. PubMed ID: 36460218
    [Abstract] [Full Text] [Related]

  • 15. [Hereditary nephrogenic diabetes insipidus].
    Morin D, Ala Y, Dumas R.
    Arch Pediatr; 1995 Jun 15; 2(6):560-7. PubMed ID: 7640759
    [Abstract] [Full Text] [Related]

  • 16. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
    Boson WL, Della Manna T, Damiani D, Miranda DM, Gadelha MR, Liberman B, Correa H, Romano-Silva MA, Friedman E, Silva FF, Ribeiro PA, De Marco L.
    Genet Test; 2006 Jun 15; 10(3):157-62. PubMed ID: 17020465
    [Abstract] [Full Text] [Related]

  • 17. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A, Pérez de Nanclares G, Madariaga L, Aguirre M, Chocron S, Madrid A, Lafita Tejedor FJ, Gil Campos M, Sánchez Del Pozo J, Ruiz Cano R, Espino M, Gomez Vida JM, Santos F, García Nieto VM, Loza R, Rodríguez LM, Hidalgo Barquero E, Printza N, Camacho JA, Castaño L, Ariceta G, RenalTube Group.
    Eur J Pediatr; 2015 Oct 15; 174(10):1373-85. PubMed ID: 25902753
    [Abstract] [Full Text] [Related]

  • 18. [Nephrogenic diabetes insipidus].
    Bichet DG.
    Nephrol Ther; 2006 Nov 15; 2(6):387-404. PubMed ID: 17081961
    [Abstract] [Full Text] [Related]

  • 19. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS, Cogdell DE, Valadez V.
    Kidney Int; 1998 Dec 15; 54(6):1909-22. PubMed ID: 9853256
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic diabetes insipidus.
    Morello JP, Bichet DG.
    Annu Rev Physiol; 2001 Dec 15; 63():607-30. PubMed ID: 11181969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.